We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Share News (AGY)

Share Price Information for Allergy Thera. (AGY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.85
Bid: 2.80
Ask: 2.90
Change: 0.00 (0.00%)
Spread: 0.10 (3.571%)
Open: 2.85
High: 2.85
Low: 2.85
Prev. Close: 2.85
AGY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EARNINGS SUMMARY: LoopUp Swings To Profit On Work-From-Home Boost

Wed, 23rd Sep 2020 14:02

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

LoopUp Group PLC - London-based cloud communications provider - Swings to pretax profit of GBP7.8 million for six months to June 30 from a GBP478,000 loss. Revenue surges 43% to GBP31.9 million. First half performance driven primarily by the large-scale migration towards working from home due to Covid-19. Enters second half with major new customer wins set to roll out, a healthy new business pipeline, and a strong balance sheet. Cash of GBP8.3 million and net debt of GBP5.3 million at June 30.

----------

Ten Entertainment Group PLC - Bedford, England-based bowling centre operator - Swings to a pretax loss of GBP7.0 million in 26 weeks ended June 28 from GBP5.9 million profit a year before. Revenue almost halves to GBP22.5 million from GBP41.4 million. Recovered quickly from lockdown as restrictions were eased. All centres now are fully open. Trading has begun well at 83% of previous levels. Confident to return the business to growth.

----------

Sigma Capital Group PLC - Manchester, England-based private rented sector specialist - Pretax profit dives 77% to GBP980,000 for six months to June 30 from GBP4.3 million a year ago. Results reflect the impact of coronavirus pandemic and national 'lockdown', which resulted in suspension of construction and lettings activities from late-March to mid-May as well as ongoing restrictions. Revenue falls 14% to GBP5.0 million from GBP5.8 million. Coronavirus crisis is estimated to have reduced activity levels by 40% in first half. Rental performance across all portfolios robust and demand for new homes remains strong, with rental prices steady at pre-pandemic levels. Dividend expected to be proposed with results for the nine-month financial period ending September 30.

----------

Staffline Group PLC - Nottingham, England-based recruitment and training group - Promotes Non-Executive Director Albert Ellis to chief executive officer role, effective from the start of October. Executive Chair Ian Lawson to move to non-executive chair role on December 31. Posts widened pretax loss of GBP47.7 million for the six months to June 30 versus a GBP12.3 million loss in the prior year period. Revenue falls 17% to GBP434.9 million. Records non-cash impairment charge of GBP35.3 million and amortisation of intangibles of GBP4.8 million. Taking actions to alleviate the probable liquidity pressures in March 2021. Expects to perform in line with expectations for 2020 despite a challenging environment. On track to achieve a positive result for 2020 on an underlying operating profit basis across all three divisions.

----------

Xeros Technology Group PLC - Rotherham, South Yorkshire-based laundry and garment technology group - Pretax loss for the six months to June 30 narrows year-on-year to GBP3.5 million from GBP8.2 million as administrative cost cut by more than half, but revenue dives to GBP215,000 from GBP1.2 million. To consolidate shares to reduce number of shares in issue. Cash of GBP6.2 million at August 31 and cash burn rate down to less than GBP500,000 per month.

----------

Anglo Asian Mining PLC - gold, copper and silver producer in Azerbaijan - Pretax profit for six months to June 30 rises 15% year-on-year to USD11.8 million from USD10.3 million. Revenue rises 6% to USD45.8 million from USD43.3 million a year before. First half production falls year-on-year to 32,501 gold equivalent ounces from 39,905 ounces. Gold bullion sales 23,979 ounces, down from 26,589 ounces. Total 2020 production target maintained at between 75,000 and 80,000 gold equivalent ounces. Declares interim dividend of 4.5 US cents per share. To consider special dividend in first-quarter of 2021. Cash of USD29.2 million and no debt at June 30.

----------

Reabold Resources PLC - oil and gas investor focused on the UK, US and Romania - Pretax loss for the six months to June 30 narrows to GBP138,000 from GBP685,000 a year ago. Revenue rises 46% to GBP570,000 from GBP390,000. Cash and cash equivalents as at June 30 GBP5.5 million. Looks forward to an exciting 2020 and beyond.

----------

Dillistone Group PLC - Basingstoke, England-based recruitment software provider - Pretax loss for six months to June 30 narrows to GBP110,000 from GBP397,000 a year ago. Revenue declines 20% to GBP3.4 million from GBP4.2 million. Management of cost base and better operational performance led to a narrowed first half loss. Covid-19 will continue to impact revenue. Non-Executive Director Mike Love to retire from the board, in line with long-term plan. Cash balances of GBP1.7 million at June 30.

----------

Equals Group PLC - London-based payments group - Pretax loss for the six months to June 30 widens year-on-year to GBP3.3 million from GBP178,223. Revenue edges up to GBP13.8 million from GBP13.6 million. Cash GBP7.6 million as of Friday last week. Positive about future prospects and confident about the outlook for the group.

----------

Warpaint London PLC - Buckinghamshire, England-based colour cosmetics business - Sales reduced 29% to GBP13.5 million in the six months to June 30 from GBP18.9 million as a result of the Covid-19 restrictions in the UK and internationally. First half pretax loss widens year-on-year to GBP1.5 million from GBP210,000 on increased costs. Resumes dividend payments. Declares interim dividend of 2.8 pence per share and one-off additional 1.3p payout. Sales for second half recover after the Covid-19 lockdown. Predicts sales for 2020 of GBP37 million, which should generate adjusted profit from operations in excess of GBP2.0 million.

----------

Cloudcall Group PLC - cloud-based software business based in Leicester - Pretax loss for the six months to June 30 widens year-on-year to GBP2.6 million from GBP1.8 million. Revenue rises 11% to GBP5.8 million from GBP5.2 million. New sales bookings recovering after initial Covid-19 impact. Resilient trading continuing into second half, with performance since the end of the period in line with management expectations.

----------

Mission Group PLC - London-based marketing group - Swings to a pretax loss of GBP1.8 million for the six months to June 30 from GBP2.7 million profit. Turnover dives to GBP58.1 million from GBP82.3 million. Net debt reduced to GBP900,000 at June 30 from GBP5.1 million at December 31. Second half of the financial year has started well under the current trading circumstances, with the impact of COVID-19 on revenue easing. Expectations to report a profit for 2020 remain unchanged.

----------

Mobile Tornado Group PLC - Harrogate, North Yorkshire-based communications company - Pretax loss for six months to June 30 widens year-on-year to GBP835,000 from GBP691,000. Revenue falls 13% to GBP1.3 million from GBP1.5 million. Recurring revenue stream stable despite the highly uncertain global economic environment. Net debt of GBP8.2 million and cash of GBP450,000 at June 30.

----------

Creo Medical Group PLC - Chepstow, Wales-based medical device company - Pretax loss for six months to June-end widens year-on-year to GBP10.5 million from GBP9.3 million a year ago. Revenue plummets 69% to GBP2.4 million from GBP7.7 million. Strong balance sheet with cash and cash equivalents of GBP70.6 million at June 30. Sees limited long-term impact of Covid-19 on business.

----------

Allergy Therapeutics PLC - Worthing, West Sussex-based biotechnology company - Pretax profit for the financial year that ended June 30 nearly doubles to GBP8.1 million from GBP4.3 million due to lower research and development costs and revenue rise. Revenue up 6% to GBP78.2 million from GBP73.7 million. Outlook for financial 2021 hard to predict accurately due to Covid-19. Sales for financial 2021 expected to grow at a similar rate to 2020 due to the anticipated reduction of new patients. Research and development expenses anticipated to be 70% higher than in 2020 as research continues with Grass MATA MPL and peanut allergy candidate vaccine. Cash balance of GBP37.0 million at June 30.

----------

Trackwise Designs PLC - Gloucestershire, England-base printed circuit technology group - Swings to pretax profit of GBP788,000 for the six months to June 30 from GBP87,000 loss a year before. Revenue rises 54% to GBP2.4 million from GBP1.5 million. Trading performance impacted by Covid-19. Annual performance will reflect the difficult economic trading conditions, a EV manufacturing contract win, and progress in two other core target markets, medical and aerospace. Net cash of GBP1.6 million at June-end.

----------

Strix Group PLC - Isle of Man-based kettle safety controls manufacturer - Pretax profit for six months to June-end broadly flat at GBP7.5 million. Revenue falls 21% to GBP34.7 million. Administrative expenses decline to GBP3.9 million from GBP6.2 million. Sees record sales in third-quarter based on replenishment of pipeline stock and the normal seasonal uplift. Maintains interim dividend payment of 2.6 pence per share. Committed to delivering a full year dividend of 7.7p, in line with 2019.

----------

ECSC Group PLC - Bradford, West Yorkshire-based cyber security services provider - Pretax loss for six months to June 30 narrows to GBP340,000 from GBP558,000 a year ago. Revenue broadly flat at GBP2.6 million. Adjusted earnings before interest, tax, depreciation and amortisation of GBP52,000 versus GBP184,000 loss. Maintaining breakeven adjusted Ebitda position throughout Covid-19 crisis. Cash of GBP1.3 million at June 30.

----------

Aseana Properties Ltd - property developer with investments in Malaysia and Vietnam - Pretax loss for six months to June-end widens year-on-year to USD8.2 million from USD5.2 million. No revenue versus GBP5.7 million a year before. Net asset value USD0.50 per share at June 30 versus USD0.55 at December 31. First half results are reflective of the challenging market conditions resulting from Covid-19 and the actions taken by governments to contain the spread of the coronavirus.

----------

By Tapan Panchal; tapanpanchal@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
27 Mar 2024 16:13

EARNINGS AND TRADING: Solid State ups outlook; Quartix trading in line

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
27 Mar 2024 11:02

AIM WINNERS & LOSERS: Norman Broadbent profit swing on rising revenue

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
12 Mar 2024 14:06

Allergy Therapeutics starts dosing patients in peanut allergy trial

(Alliance News) - Allergy Therapeutics PLC on Tuesday said it has commenced subcutaneous dosing of peanut allergic patients in its phase 1/2a Protect trial.

Read more
1 Mar 2024 15:49

UK shareholder meetings calendar - next 7 days

Monday 4 March 
Ascent Resources PLCGM re bonus issue of preference shares
JPMorgan Emerging Europe, Middle East & Africa Securities PLCAGM
Lexington Gold LtdAGM
Tuesday 5 March 
Ajax Resources PLCGM re extension of investment mandate
Beowulf Mining PLCGM re capital raise
CC Japan Income & Growth Trust PLCAGM
Driver Group PLCAGM
Edinburgh Worldwide Investment Trust PLCAGM
Jersey Electricity PLCAGM
Wednesday 6 March 
Ecofin Global Utilities & Infrastructure Trust PLCAGM
Mila Resources PLCAGM
Paragon Banking Group PLCAGM
Thursday 7 March 
Asia Strategic Holdings LtdAGM
CT UK Capital & Income Investment Trust PLCAGM
Henderson Opportunities Trust PLCAGM
XPS Pensions Group PLCGM re directors' remuneration policy 2024
Friday 8 March 
Allergy Therapeutics PLCAGM
All Things Considered Group PLCAGM
Chenavari Toro Income Fund LtdAGM
Neo Energy Metals PLCAGM
Schroder UK Mid Cap Fund PLCAGM
Silverwood Brands PLCGM re proposed share capital reduction
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
14 Feb 2024 10:22

Allergy Therapeutics forecasts revenue drop but trials going well

(Alliance News) - Allergy Therapeutics PLC on Wednesday said revenue decreased in its latest half year, and expects to require further funding soon.

Read more
5 Feb 2024 14:09

TRADING UPDATES: Alliance Pharma appoints chair; FireAngel sales down

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
30 Jan 2024 10:38

Allergy Therapeutics resumes trading on AIM; annual revenue plunges

(Alliance News) - Allergy Therapeutics PLC on Tuesday resumed trading on AIM after the release of its annual results.

Read more
27 Dec 2023 14:17

IN BRIEF: Allergy Therapeutics amends facility, plans warrant issue

Allergy Therapeutics PLC - Sussex-based biotechnology company specialising in allergy vaccines - Shares rise as firm enters amendment to the facility agreement it reached in early April with SkyGem Acquisition Ltd and Southern Fox Investments Ltd. Deal provides Allergy Therapeutics with a GBP40 million secured loan facility of which GBP32.5 million is uncommitted. Facility is available to drawdown between January 15 and the same day in 2026, with interest payable semi-annually at 12% per year and a January 15, 2027 repayment date.

Read more
15 Dec 2023 21:09

EARNINGS AND TRADING: Redx full year revenue tumbles; loss widens

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
13 Dec 2023 10:11

Allergy Therapeutics shares jump as hails grass allergy jab data

(Alliance News) - Allergy Therapeutics PLC on Wednesday said that phase-3 trials of its grass allergy injection yielded positive results, moving the product closer to market entry.

Read more
13 Dec 2023 09:55

AIM WINNERS & LOSERS: Impellam climbs on GBP483 million takeover offer

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
14 Nov 2023 11:56

Allergy Therapeutics says allergy therapy trial meets primary endpoint

(Alliance News) - Allergy Therapeutics PLC on Tuesday said that a trial evaluating the efficacy of its subcutaneous allergen-specific immunotherapy candidate has met its primary endpoint.

Read more
14 Nov 2023 10:59

AIM WINNERS & LOSERS: Renalytix revenue halves; DP Poland trades well

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
6 Nov 2023 12:33

IN BRIEF: Allergy Therapeutics extends cash runway until end of 2023

Allergy Therapeutics PLC - West Sussex, England-based commercial biotechnology company - Says it continued to work on initiatives to improve cost control and manage working capital alongside trading broadly in line with expectations for the current financial year to date. Says it has extended its cash runway and anticipates to require additional funding by the end of December. Further, says discussions with some major shareholders regarding a subscription and open offer announced in October have progressed. Says that the pivotal phase 3 grass G306 modified allergen tyrosine adsorbed monophosphoryl lipid A trial remains on track to report interim results this month. Via G306, the company aims to release an immunotherapy for grass allergy.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.